drugset
drugset / Trial / NCT06087211

Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain

NCT06087211 ↗

Completed 90 enrolled National Cancer Institute, Egypt
RandomizedParallel-groupDouble-blindPrevention

Summary

This study aims to evaluate the effect of combined duloxetine and IV Magnesium sulphate to decrease acute and chronic post mastectomy pain. The study will be conducted in National Cancer Institute and all the participants will be enrolled from female patients scheduled for modified radical mastectomy under general anesthesia in National Cancer Institute, Cairo University.

Timeline

Start
2023-10-10
Primary completion
2025-01-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 30 mg Oral
Comparator Magnesium Sulfate Other / unclassified 50 mg/kg Intravenous

Indications

myofascial pain syndrome